Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Phase 3
Completed
- Conditions
- Dry Eye
- Interventions
- Drug: Omega 3 fatty acidDrug: Placebos
- First Posted Date
- 2019-11-29
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- OmegaD LLC
- Target Recruit Count
- 322
- Registration Number
- NCT04181593
- Locations
- 🇺🇸
Shettle Eye Research inc, Largo, Florida, United States
🇺🇸Clayton Eye Clinical Research, Morrow, Georgia, United States
🇺🇸Heart of America Eye Care, Shawnee Mission, Kansas, United States
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
- First Posted Date
- 2016-12-02
- Last Posted Date
- 2019-12-13
- Lead Sponsor
- OmegaD LLC
- Target Recruit Count
- 180
- Registration Number
- NCT02980224
© Copyright 2025. All Rights Reserved by MedPath